Scotts Miracle-Gro (SMG) expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue. President Trump deserves credit and praise for taking this bold action, as it reflects the will of the people and sets the stage for much-needed research into the medical use of cannabis. Just as importantly, this will help deliver a blow to the illicit cannabis market by strengthening the financial viability of the legal and regulated industry that employs over 425,000 people and contributes $100 billion to the economy,” said Chairman and CEO Jim Hagedorn.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro: Strong Buy Recommendation Based on Promising Growth Projections and Valuation Upside
- Scotts Miracle-Gro Faces Financial Uncertainty Amid U.S. Legislative Challenges
- Scotts Miracle-Gro, Columbus Crew expand long-standing partnership
- Scotts Miracle-Gro Secures $2 Billion Loan Facilities
- Scotts Miracle-Gro Updates Long-Term Incentive Plan